Adult diffuse gliomas produce mRNA transcripts encoding EGFR isoforms lacking a tyrosine kinase domain

International Journal of Oncology

Volumn 40, Issue 4, 2012, Pages 1142-1152

  Guillaudeau, Angélique ^a   Durand, Karine ^a   Rabinovitch Chable, Hélène ^a   Pommepuy, Isabelle ^a   Mesturoux, Laura ^a   Robert, Sandrine ^a   Chaunavel, Alain ^a   Moreau, Jean Jacques ^a   Labrousse, François ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

EGFR isoforms; EGFR mRNA variants; Epidermal growth factor receptor; Glioblastoma; Gliomas

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; PROTEIN TYROSINE KINASE;

ARTICLE; ASTROCYTOMA; CLINICAL ARTICLE; EXON; EXTRACELLULAR MATRIX; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETIC ASSOCIATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OLIGODENDROGLIOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; RNA TRANSCRIPTION;

ADULT; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SURVIVAL RATE;

EID: 84858640124     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1287     Document Type: Article

References (42)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109, 2007. (Pubitemid 47103521)
2. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M and Schackert G: Long-term survival with glioblastoma multiforme. Brain 130: 2596-2606, 2007. (Pubitemid 47511715)
3. Andersson U, Guo D, Malmer B, Bergenheim AT, Brannstrom T, Hedman H and Henriksson R: Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Acta Neuropathol 108: 135-142, 2004. (Pubitemid 39136299)
4. Bredel M, Pollack IF, Hamilton RL and James CD: Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood. Clin Cancer Res 5: 1786-1792, 1999. (Pubitemid 29334460)
5. McLendon RE, Turner K, Perkinson K and Rich J: Second messenger systems in human gliomas. Arch Pathol Lab Med 131: 1585-1590, 2007. (Pubitemid 47606727)
6. Potti A, Forseen SE, Koka VK, Pervez H, Koch M, Fraiman G, Mehdi SA and Levitt R: Determination of HER-2/neu overexpression and clinical predictors of survival in a cohort of 347 patients with primary malignant brain tumors. Cancer Invest 22: 537-544, 2004. (Pubitemid 39506874)
7. Schlegel J, Stumm G, Brandle K, Merdes A, Mechtersheimer G, Hynes NE and Kiessling M: Amplification and differential expression of members of the erbB-gene family in human glioblastoma. J Neurooncol 22: 201-207, 1994.
8. Tabori U, Rienstein S, Dromi Y, Leider-Trejo L, Constantini S, Burstein Y, Dvir R, Amariglio N, Toren A, Rechavi G, Izraeli S and Aviram A: Epidermal growth factor receptor gene amplification and expression in disseminated pediatric low-grade gliomas. J Neurosurg 103: 357-361, 2005. (Pubitemid 44954891)
9. Gil-Benso R, Lopez-Gines C, Benito R, Lopez-Guerrero JA, Callaghan RC, Pellin A, Roldan P and Cerda-Nicolas M: Concurrent EGFR amplification and TP-53 mutation in glioblastomas. Clin Neuropathol 26: 224-231, 2007. (Pubitemid 47403417)
10. Nakamura JL: The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications. Expert Opin Ther Targets 11: 463-472, 2007.
11. Okada Y, Ohno C, Ueki K, Ogino M, Kawamoto S and Kim P: Comparison of numerical change of epidermal growth factor receptor gene among pre- and postradiation glioma, and gliosis, and its clinical use. Brain Tumor Pathol 24: 15-18, 2007. (Pubitemid 46836352)
12. Schober R, Bilzer T, Waha A, et al: The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trial. Clin Neuropathol 14: 169-174, 1995.
13. Shinojima N, Tada K, Shiraishi S, Kamiryo T, Kochi M, Nakamura H, Makino K, Saya H, Hirano H, Kuratsu J, Oka K, Ishimaru Y and Ushio Y: Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res 63: 6962-6970, 2003. (Pubitemid 37322983)
14. Torp SH, Helseth E, Dalen A and Unsgaard G: Epidermal growth factor receptor expression in human gliomas. Cancer Immunol Immunother 33: 61-64, 1991.
15. Torp SH, Helseth E, Ryan L, Stolan S, Dalen A and Unsgaard G: Amplification of the epidermal growth factor receptor gene in human gliomas. Anticancer Res 11: 2095-2098, 1991.
16. Gan HK, Kaye AH and Luwor RB: The EGFRvIII variant in glioblastoma multiforme. J Clin Neurosci 16: 748-754, 2009.
17. Lal A, Glazer CA, Martinson HM, Friedman HS, Archer GE, Sampson JH and Riggins GJ: Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. Cancer Res 62: 3335-3339, 2002. (Pubitemid 34651373)
18. Sampson JH, Heimberger AB, Archer GE, Aldape KD, Friedman AH, Friedman HS, Gilbert MR, Herndon JE II, McLendon RE, Mitchell DA, Reardon DA, Sawaya R, Schmittling RJ, Shi W, Vredenburgh JJ and Bigner DD: Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. J Clin Oncol 28: 4722-4729, 2010.
19. Maihle NJ, Baron AT, Barrette BA, Boardman CH, Christensen TA, Cora EM, Faupel-Badger JM, Greenwood T, Juneja SC, Lafky JM, Lee H, Reiter JL and Podratz KC: EGF/ErbB receptor family in ovarian cancer. Cancer Treat Res 107: 247-258, 2002.
20. Reiter JL and Maihle NJ: Characterization and expression of novel 60-kDa and 110-kDa EGFR isoforms in human placenta. Ann NY Acad Sci 995: 39-47, 2003. (Pubitemid 36706612)
21. Reiter JL, Threadgill DW, Eley GD, Strunk KE, Danielsen AJ, Sinclair CS, Pearsall RS, Green PJ, Yee D, Lampland AL, Balasubramaniam S, Crossley TD, Magnuson TR, James CD and Maihle NJ: Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms. Genomics 71: 1-20, 2001. (Pubitemid 32097198)
22. Flickinger TW, Maihle NJ and Kung HJ: An alternatively processed mRNA from the avian c-erbB gene encodes a soluble, truncated form of the receptor that can block ligand-dependent transformation. Mol Cell Biol 12: 883-893, 1992.
23. Weber W, Gill GN and Spiess J: Production of an epidermal growth factor receptor-related protein. Science 224: 294-297, 1984. (Pubitemid 14172514)
24. Cadena DL and Gill GN: Expression and purification of the epidermal growth factor receptor extracellular domain utilizing a polycistronic expression system. Protein Expr Purif 4: 177-186, 1993.
25. Greenfield C, Hiles I, Waterfield MD, Federwisch M, Wollmer A, Blundell TL and McDonald N: Epidermal growth factor binding induces a conformational change in the external domain of its receptor. EMBO J 8: 4115-4123, 1989. (Pubitemid 20066854)
26. Basu A, Raghunath M, Bishayee S and Das M: Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation. Mol Cell Biol 9: 671-677, 1989. (Pubitemid 19038870)
27. Hirsch FR, Varella-Garcia M, Bunn PA Jr, Di Maria MV, Veve R, Bremmes RM, Baron AE, Zeng C and Franklin WA: Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 21: 3798-3807, 2003. (Pubitemid 46606235)
28. Guillaudeau A, Durand K, Pommepuy I, Robert S, Chaunavel A, Lacorre S, De Armas R, Bourtoumieux S, El Demery M, Moreau JJ and Labrousse F: Determination of EGFR status in gliomas: usefulness of immunohistochemistry and fluorescent in situ hybridization. Appl Immunohistochem Mol Morphol 17: 220-226, 2009.
29. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
30. Korshunov A, Sycheva R and Golanov A: Molecular stratification of diagnostically challenging high-grade gliomas composed of small cells: the utility of fluorescence in situ hybridization. Clin Cancer Res 10: 7820-7826, 2004. (Pubitemid 39587519)
31. Marks RA, Zhang S, Montironi R, McCarthy RP, MacLennan GT, Lopez-Beltran A, Jiang Z, Zhou H, Zheng S, Davidson DD, Baldridge LA and Cheng L: Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis. Prostate 68: 919-923, 2008. (Pubitemid 351794156)
32. Durand K, Guillaudeau A, Pommepuy I, Mesturoux L, Chaunavel A, Gadeaud E, Porcheron M, Moreau JJ and Labrousse F: Alpha-internexin expression in gliomas: relationship with histological type and 1p, 19q, 10p and 10q status. J Clin Pathol 64: 793-801, 2011.
33. Durand KS, Guillaudeau A, Weinbreck N, De Armas R, Robert S, Chaunavel A, Pommepuy I, Bourthoumieu S, Caire F, Sturtz FG and Labrousse FJ: 1p19q LOH patterns and expression of p53 and Olig2 in gliomas: relation with histological types and prognosis. Mod Pathol 23: 619-628, 2010.
34. Hirose T, Ishizawa K and Shimada S: Utility of in situ demonstration of 1p loss and p53 overexpression in pathologic diagnosis of oligodendroglial tumors. Neuropathology 30: 586-596, 2010.
35. Ligon KL, Alberta JA, Kho AT, Weiss J, Kwaan MR, Nutt CL, Louis DN, Stiles CD and Rowitch DH: The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol 63: 499-509, 2004. (Pubitemid 38669670)
36. Okada M, Yano H, Hirose Y, Nakayama N, Ohe N, Shinoda J and Iwama T: Olig2 is useful in the differential diagnosis of oligodendrogliomas and extraventricular neurocytomas. Brain Tumor Pathol 28: 157-161, 2011.
37. Coulibaly B, Nanni I, Quilichini B, Gaudart J, Metellus P, Fina F, Boucard C, Chinot O, Ouafik L and Figarella-Branger D: Epidermal growth factor receptor in glioblastomas: correlation between gene copy number and protein expression. Hum Pathol 41: 815-823, 2010.
38. Ilekis JV, Stark BC and Scoccia B: Possible role of variant RNA transcripts in the regulation of epidermal growth factor receptor expression in human placenta. Mol Reprod Dev 41: 149-156, 1995.
39. Voelzke WR, Petty WJ and Lesser GJ: Targeting the epidermal growth factor receptor in high-grade astrocytomas. Curr Treat Options Oncol 9: 23-31, 2008.
40. Albitar L, Pickett G, Morgan M, Wilken JA, Maihle NJ and Leslie KK: EGFR isoforms and gene regulation in human endometrial cancer cells. Mol Cancer 9: 166, 2010.
41. Lafky JM, Wilken JA, Baron AT and Maihle NJ: Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochim Biophys Acta 1785: 232-265, 2008.
42. Shibata MA, Ambati J, Shibata E, Albuquerque RJ, Morimoto J, Ito Y and Otsuki Y: The endogenous soluble VEGF receptor-2 isoform suppresses lymph node metastasis in a mouse immunocompetent mammary cancer model. BMC Med 8: 69, 2010.